Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanja Fehm

Showing results (261-270 of 371) with videos related to

Pageof 38
Sort By:
Breast Care (Basel, Switzerland)|February 26, 2019
Validation of a Nomogram Predicting Non-Sentinel Lymph Node Metastases among Patients with Breast Cancer after Primary Systemic Therapy - a transSENTINA SubstudyCornelia Liedtke, Dennis Görlich, Ingo Bauerfeind, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2018
Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44)Michael Untch, Gunter von Minckwitz, Bernd Gerber, et al.
Cancers|March 6, 2021
Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic ScoresKerstin Riecke, Volkmar Müller, Rudolf Weide, et al.
Clinical Breast Cancer|July 19, 2018
Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells-Results From the SUCCESS A TrialPhilip Hepp, Peter A Fasching, Matthias W Beckmann, et al.
Clinical Breast Cancer|June 19, 2023
Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer PatientsMarie Tzschaschel, Thomas W P Friedl, Fabienne Schochter, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2021
Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trialCaroline A Peuker, Sarvenaz Yaghobramzi, Corinna Grunert, et al.
Nanotechnology|June 27, 2019
From in vitro to ex vivo: subcellular localization and uptake of graphene quantum dots into solid tumorsDavid Kersting, Stefan Fasbender, Rabea Pilch, et al.
Breast (Edinburgh, Scotland)|November 28, 2016
Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trialLukas Schwentner, Gisela Helms, Valentina Nekljudova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2020
Gene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage Hormone Receptor-Positive Breast Cancer PatientsWerner Schroth, Florian A Büttner, Siarhei Kandabarau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast CancerWolfgang J Janni, Brigitte Rack, Leon W M M Terstappen, et al.
Pageof 38

Showing results (261-270 of 371) with videos related to

Sort By:
Pageof 38
Breast Care (Basel, Switzerland)|February 26, 2019
Validation of a Nomogram Predicting Non-Sentinel Lymph Node Metastases among Patients with Breast Cancer after Primary Systemic Therapy - a transSENTINA SubstudyCornelia Liedtke, Dennis Görlich, Ingo Bauerfeind, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2018
Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44)Michael Untch, Gunter von Minckwitz, Bernd Gerber, et al.
Cancers|March 6, 2021
Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic ScoresKerstin Riecke, Volkmar Müller, Rudolf Weide, et al.
Clinical Breast Cancer|July 19, 2018
Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells-Results From the SUCCESS A TrialPhilip Hepp, Peter A Fasching, Matthias W Beckmann, et al.
Clinical Breast Cancer|June 19, 2023
Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer PatientsMarie Tzschaschel, Thomas W P Friedl, Fabienne Schochter, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2021
Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trialCaroline A Peuker, Sarvenaz Yaghobramzi, Corinna Grunert, et al.
Nanotechnology|June 27, 2019
From in vitro to ex vivo: subcellular localization and uptake of graphene quantum dots into solid tumorsDavid Kersting, Stefan Fasbender, Rabea Pilch, et al.
Breast (Edinburgh, Scotland)|November 28, 2016
Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trialLukas Schwentner, Gisela Helms, Valentina Nekljudova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2020
Gene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage Hormone Receptor-Positive Breast Cancer PatientsWerner Schroth, Florian A Büttner, Siarhei Kandabarau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast CancerWolfgang J Janni, Brigitte Rack, Leon W M M Terstappen, et al.
Pageof 38